主营产品:

小鼠肺细胞,仓鼠体细胞,小鼠神经细胞,小鼠脑细胞,小鼠**细胞,仓鼠细胞,兔肝细胞,兔上皮细胞,兔胰岛细胞,猪上皮细胞

产品详情

MicroVue C3a Plus EIA** (For C3 activation)[产品打印页面]

如果您对该产品感兴趣的话,可以
产品名称: MicroVue C3a Plus EIA** (For C3 activation)
产品型号: A031/A032 (CE)
产品展商: Quidel
美元($)价格: 626.00 元
欧元(€)价格: 0.00 元
人民币(¥)价格: 0.00 元
产品文档: 无相关文档
发布时间:2019-08-21

简单介绍

MicroVue C3a Plus EIA** (For C3 activation)


MicroVue C3a Plus EIA** (For C3 activation)  的详细介绍

For Research Use Only in the United States. Not for use in diagnostic procedures.

The MicroVue C3a Plus EIA measures the amount of C3a-desArg present in human plasma and serum.

C3a is generated during the activation of the complement system via the classical or alternative pathway. The anaphylatoxin C3a itself is very short lived and in serum is cleaved rapidly to the more stable C3a-desArg. Therefore, quantitation of C3a-desArg allows reliable conclusions about the level of complement activation in a test sample. For convenience, we refer to both forms as C3a. The MicroVue C3a Plus EIA measures concentrations of C3a in human plasma and sera. It uses a proprietary monoclonal antibody to a neo-epitope on C3a to capture C3a in the solid phase. The trapped C3a is subsequently detected by HRP-labeled antibodies to C3a antigens. This test provides a rapid, non-radioactive method for assessing C3a levels. It is designed for investigations into the role and or status of complement activation in numerous research and clinical settings. An EIA for the detection of C3a (C3a-desArg) in human serum and plasma.

References

Sefton, M.V., et al. Using ELISA to evaluate complement activation by reference biomaterials, J Materials Science, 5:622-627, 1994.

Mold, C, Tamerius, J.D., et al. Complement activation during painful crisis in sickle cell anemia, Clinical Immunology and Immunopathology, 70:3,314-320, 1995.

Rinder, C, et al., Blockade of C5a and SC5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation, J. Clin. Invest., 96:3,1564-1572, 1995.

Rollins, et al. Monoclonal Antibodies directed against human C5 and C8 block complement mediated damage of xenogenic cells and organs, Transplantation, 60:11, 1284-1292, 1995.

Sorace, J., et al., Role of atheroma liposomes and malondialdehyde modified low density lipoproteins in complement activation, Pathobiology, 64:73-78, 1996.

Shorey, et al. A macrophage invasion mechanism of mycobacteria, Science, 277:1091-93, 1997.

Yeh, G., et al. A soluble chimeric complement inhibitory protein that possesses both DAF and Factor I cofactor activities, J. Immuno., 158:2872-2881, 1997.

Features & Benefits

Feature Benefit

Product Specifications

Product Spec Name Product Spec Data
Format

ELISA

Assay time

135 minutes

Test/kit

96 wells/plate

Sample Type

Serum, K2 EDTA plasma

Ordering Information

Catalog Number Description
A031

ELISA Kit, control included

A032 XUS

ELISA Kit, control included

产品留言
标题
联系人
联系电话
内容
验证码
点击换一张
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
Copyright@ 2003-2019  上海斯信生物科技有限公司  版权所有   电话:021-33779008分机117 传真:021-65538480 地址:上海市闵行区新源路1356弄1-7号C801 邮编:201108
         沪ICP备17033327号-1   

沪公网安备 31011202007337号